PAVAN TRADING LTD

Pavan Trading Ltd specializes in intra-articular viscosupplements, which are designed to supplement or restore the natural properties of synovial fluid in joints. These devices are primarily used to treat joint disorders like osteoarthritis by improving joint lubrication and cushioning, thereby enhancing mobility and reducing pain. The company’s portfolio focuses exclusively on this category of products.

Pavan Trading Ltd is based in the United States. Its devices are manufactured and intended for use within the U.S. regulatory framework, adhering to FDA requirements for medical devices. The company’s products are tailored to meet the needs of the American healthcare system, including compliance with local standards for joint therapy solutions.

Pavan Trading Ltd’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is a central repository for tracking medical devices authorized for use in the U.S., ensuring transparency and traceability of high-risk products like viscosupplements, which are classified as Class III under FDA regulations.

Pavan Trading Ltd’s viscosupplements are classified as Class III medical devices by the FDA. This classification applies to products that support or sustain human life, are of substantial importance in preventing impairment of human health, or present a potential unreasonable risk of illness or injury. Due to their role in joint therapy and pain management, these devices undergo rigorous review to ensure safety and efficacy.